Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Tilray, Inc.
  6. News
  7. Summary
    TLRY   US88688T1007

TILRAY, INC.

(TLRY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cannabis Brief: But CIBC Sees Tilray and HEXO As Likely Profitable Next Year In Terms of Positive Adjusted EBITDA, adds BNN TV

09/23/2021 | 04:28pm EDT


© MT Newswires 2021
All news about TILRAY, INC.
10/21SUNDIAL GROWERS : Unconfirmed Social Media Chatter Claims Possible Acquisition of Sundial ..
MT
10/21Tilray Names Blair MacNeil as President, Tilray Canada
CI
10/21SOCIAL BUZZ : Walstreetbets Move Lower Premarket Thursday
MT
10/20TILRAY : Selects Great North Distributors as Exclusive Agent to Sell Adult-Use Cannabis in..
MT
10/20TILRAY : Signs Adult-Use Cannabis Distribution Deal with Great North Distributors in Canad..
MT
10/20TILRAY : Signs Distribution Agreement With Great North Distributors for Adult-Use Cannabis..
BU
10/20Tilray, Inc. and Great North Distributors, Inc. Announces A Signed National Brokerage A..
CI
10/20SOCIAL BUZZ : Wallstreetbets Stocks Mixed Pre-Market Wednesday
MT
10/19SOCIAL BUZZ : Tilray, ContextLogic, Alibaba, SmileDirectClub Biggest Wallstreetbets Gainer..
MT
10/19TILRAY : Names Bacardi Exec as New Canada Business Head
MT
More news
Analyst Recommendations on TILRAY, INC.
More recommendations
Financials (USD)
Sales 2022 758 M - -
Net income 2022 104 M - -
Net Debt 2022 - - -
P/E ratio 2022 52,8x
Yield 2022 -
Capitalization 5 134 M 5 134 M -
Capi. / Sales 2022 6,77x
Capi. / Sales 2023 3,85x
Nbr of Employees 2 100
Free-Float 98,6%
Chart TILRAY, INC.
Duration : Period :
Tilray, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TILRAY, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 11,08 $
Average target price 14,58 $
Spread / Average Target 31,6%
EPS Revisions
Managers and Directors
Irwin David Simon Chairman & Chief Executive Officer
Carl A. Merton Chief Financial Officer
Joshua Eades Chief Science Officer
Catherine Jacobson Vice President-Regulatory & Medical Affairs
Lloyd Brathwaite Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
TILRAY, INC.39.95%5 356
JOHNSON & JOHNSON3.83%430 148
ROCHE HOLDING AG15.79%339 425
PFIZER, INC.16.27%240 303
NOVO NORDISK A/S56.55%239 079
ELI LILLY AND COMPANY42.84%218 640